Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Gross Margin (2019 - 2025)

Pulmonx (LUNG) has disclosed Gross Margin for 7 consecutive years, with 74.65% as the latest value for Q3 2025.

  • On a quarterly basis, Gross Margin rose 95.0% to 74.65% in Q3 2025 year-over-year; TTM through Sep 2025 was 73.3%, a 86.0% decrease, with the full-year FY2024 number at 74.0%, up 9.0% from a year prior.
  • Gross Margin was 74.65% for Q3 2025 at Pulmonx, up from 72.11% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 75.21% in Q1 2022 to a low of 71.52% in Q1 2021.
  • A 5-year average of 73.79% and a median of 73.99% in 2021 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: surged 4644bps in 2021, then plummeted -235bps in 2023.
  • Pulmonx's Gross Margin stood at 74.78% in 2021, then fell by -3bps to 72.51% in 2022, then grew by 3bps to 74.7% in 2023, then decreased by -1bps to 74.02% in 2024, then grew by 1bps to 74.65% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Gross Margin are 74.65% (Q3 2025), 72.11% (Q2 2025), and 72.51% (Q1 2025).